UCSF Scientists Map Maternal-Fetal Interface, Uncover New Cell Type and Insights into Pregnancy Complications

Scientists at the University of California, San Francisco (UCSF), have created a comprehensive map of the biological connection between a pregnant woman and her developing baby, known as the maternal-fetal interface. This groundbreaking research has identified a previously unknown cell type and provided new insights into conditions such as preeclampsia, preterm birth, and miscarriage.

Study Methodology and Scope

Published in Nature on April 8, the study utilized advanced single-cell and spatial tools. Researchers analyzed approximately 200,000 individual cells and compared these with nearly 1 million cells within their original positions in uterine and placental tissue. This sophisticated approach enabled the identification of various cell types, the tracking of their development, and the assessment of their links to pregnancy complications.

Jingjing Li, PhD, an associate professor at UCSF’s Department of Neurology, and the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, served as the senior author of the study. Susan J. Fisher, PhD, a professor of Obstetrics, Gynecology and Reproductive Sciences at UCSF, was a co-leader of the research.

The maternal-fetal interface is a temporary structure composed of uterine and placental cells. It forms approximately one week after fertilization and is crucial for fetal growth and the maintenance of maternal health throughout pregnancy.

Key Discoveries

The research yielded several significant findings regarding the maternal-fetal connection:

• Discovery of a Novel Maternal Cell Type: A previously unknown maternal cell type was identified at the site where fetal placental cells first enter the uterus. These cells appear to regulate the depth of placental cell invasion into uterine tissue, a process vital for establishing adequate blood flow to the fetus.

• Cannabinoid Receptor Link: The newly discovered cells were found to possess a cannabinoid receptor. Exposure to cannabinoid molecules caused these cells to further restrict placental cell invasion.

  "This finding might offer a biological basis for observed associations between cannabis use during pregnancy and poorer outcomes," suggested Cheng Wang, PhD, the study's first author.

• Genetic Data Integration for Complications: The research team integrated genetic data from over 10,000 patients, mapping genetic risk signals for conditions including preterm birth, preeclampsia, and miscarriage onto regulatory DNA regions that control gene activity. This method allowed for the identification of specific cell types and states most strongly associated with each condition.

• Insights into Preeclampsia: Focusing on preeclampsia, a disorder characterized by high blood pressure during pregnancy, researchers observed that the most affected cell types are involved in the remodeling of the mother’s uterine blood vessels. This remodeling is necessary to supply sufficient blood to the placenta. The findings suggest that preeclampsia may result from disrupted communication between maternal and fetal cells that typically coordinate this process.

Future Research Directions

With a detailed map of healthy pregnancies now established, the researchers intend to expand their studies to analyze complicated pregnancies. This future work aims to identify potential targets for therapeutic interventions.